Two Sigma Advisers
GHSI

Two Sigma Advisers’s Guardion Health Sciences, Inc. Common Stock GHSI Stock Holding History

Two Sigma Advisers’s Portfolio GHSI Stock Details GHSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-540
Closed -$17K – 2956
2021
Q4 		$17K Buy
540
+50
+10% +$2.69K ﹤0.01% 2552
2021
Q3 		$31K Buy
+490
New +$32.6K ﹤0.01% 2393

Other funds holding GHSI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Two Sigma Advisers's GHSI Position: Q1 2022 in Review

Two Sigma Advisers sold out of Guardion Health Sciences, Inc. Common Stock (GHSI) in Q1 2022, closing a stake of 540 shares — an estimated $17K sold.

Two Sigma Advisers first reported a position in GHSI in Q3 2021 and held it in 2 quarters. The position peaked at $31K in Q3 2021. 20 funds tracked by Wall St. Rank hold GHSI as of Q1 2022.

  • Two Sigma Advisers reported no remaining Guardion Health Sciences, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 540 Guardion Health Sciences, Inc. Common Stock shares in Q1 2022, an estimated $17K.
  • Two Sigma Advisers first reported a position in Guardion Health Sciences, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • Two Sigma Advisers's Guardion Health Sciences, Inc. Common Stock position peaked at $31K in Q3 2021.
  • 20 funds tracked by Wall St. Rank held Guardion Health Sciences, Inc. Common Stock as of Q1 2022.

Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.